Last modified: April 5, 2021
Differences Between Mesothelioma & Lung Cancer Development
While mesothelioma and lung cancer can develop after exposure to asbestos, each occurs in different areas of the body. Lung cancer develops in the lung itself, while mesothelioma usually develops in the lining of the lung. Mesothelioma can also develop in the lining of the abdomen, heart or testes. Mesothelioma of the lung is called pleural mesothelioma.
The two cancers grow differently. Lung cancer tends to grow in individual masses, known as nodules, with defined boundaries. Mesothelioma starts as tiny tumor nodules that scatter the mesothelial lining, and eventually grow together to form a sheath-like tumor around the organ.
Lung cancer has a tendency to spread or metastasize early to other organs, while mesothelioma tends to be a more locally aggressive disease that remains within one body cavity.
Another major difference is the incidence rate of the two conditions. Lung cancer is the second-most-common cancer in the U.S. with about 222,500 new cases annually.
Doctors diagnose roughly 2,800 cases of malignant mesothelioma, which includes all four types of the asbestos-related cancer, each year.
Mesothelioma is almost exclusively the result of asbestos exposure, while the majority of lung cancer cases are attributed to tobacco use and environmental exposures to substances such as radon gas and secondhand smoke.
And while smoking does not influence risk of mesothelioma, it greatly increases an individual’s risk of developing lung cancer. Those with the highest risk of lung cancer are smokers with a history of asbestos exposure.
By themselves, each risk factor damages lung tissue and makes it more susceptible to diseases. So when smoking and asbestos are combined, an individual’s lung cancer risk increases at least fiftyfold.
Facts About Mesothelioma
- Statistics about mesothelioma show that more than 80 percent of mesothelioma cases are the result of asbestos exposure.
- This cancer typically takes 20 to 50 years to develop after initial exposure to asbestos
Facts About Lung Cancer
- 90 percent of all lung cancer deaths are attributed to tobacco use.
- Radon exposure is the second-leading cause of lung cancer.
- Lung cancer has a shorter latency period and may appear 10 to 30 years after first exposure to a carcinogen like asbestos or cigarette smoke.
Similarities Between Mesothelioma and Lung Cancer
Death rates by state for mesothelioma and lung cancer tend to correlate with each other. The five states with the most mesothelioma deaths also have the most lung cancer deaths.
Each disease can take decades to develop yet only months to spread to distant organs. Both have similar diagnostic procedures and treatment techniques.
In addition, lung cancer and mesothelioma have overlapping symptoms. They both commonly cause chest pain, coughing, difficulty breathing, fatigue and weight loss. If a patient has these symptoms along with a history of asbestos exposure and/or a history of smoking, doctors should immediately suspect lung cancer or mesothelioma.
But despite having a number of similarities, lung cancer and mesothelioma differ in physical characteristics and non-asbestos risk factors.
Diagnosing Mesothelioma and Lung Cancer
To diagnose either type of cancer, a doctor will need to perform a biopsy. The appearance on CT scan or PET scan alone is not a reliable way to differentiate between lung cancer and mesothelioma. Biopsies may be performed via a bronchoscopy, needle biopsy or thoracoscopic surgery.
During a bronchoscopy, the doctor inserts a small camera down the throat and into the airways of the lung to detect abnormalities such as visible tumor growth. If the doctor finds irregular growth, he or she may collect a cell sample and test it for cancer.
A needle biopsy involves placing a small needle into the tumor using an ultrasound machine or CT scan to localize it. The procedure is performed under local anesthesia.
To collect a larger sample, however, a minor biopsy surgery under general anesthesia is required. A small camera is inserted between the ribs to look inside the chest and obtain samples of the fluid. During this procedure, fluid buildup may be suctioned out and a pleurodesis performed to decrease the risk of the fluid collecting again.
Most patients with pleural mesothelioma will either show pleural thickening (extensive scarring in the lining of the chest cavity) or a pleural effusion, which is fluid buildup in their chest cavity. This fluid may be tested for cancer cells, but it isn’t a reliable way to confirm a diagnosis.
With lung cancer, you don’t necessarily have the thickening of the lining of the chest cavity. However, it is not uncommon for lung cancer patients to present with pleural effusions, which can sometimes make it difficult to establish the diagnosis.
Treating These Cancers
For mesothelioma and lung cancer, treatment options largely depend on how much the cancer has spread, which is also referred to as the stage of the cancer. Most treatment plans include some combination of surgery, radiation therapy or chemotherapy.
If the cancer is localized to the lung area, surgery may be able to remove all of the tumor growth. But surgeries vary by specific type of cancer.
- To treat pleural mesothelioma a surgeon may remove the lining of the lung, the affected portion of the lung or the entire cancerous lung and its linings.
- Typical lung cancer surgeries include removing a small portion of the lung, a lobe of the lung or the entire lung.
For both types of cancer, chemotherapy and radiation therapy are also considered as possible additional approaches to treatment. If the mesothelioma or lung cancer is localized, either treatment can be used to shrink tumor growth and potentially kill all tumor cells. When used in this potentially curative way, chemotherapy and radiation therapy are typically combined with surgery. These treatments can still be used if the cancer has spread beyond its original location. In these cases, treatments are palliative and aim to reduce symptoms.
Experimental therapies are being tested through clinical trials for both cancers. Some of these innovative therapies include immunotherapy, gene therapy, photodynamic therapy and cryotherapy. Photodynamic therapy is used more routinely in the treatment of lung cancer than in mesothelioma.
One year after diagnosis, survival rates for lung cancer and mesothelioma are close: 42 percent for lung cancer patients and 39 percent for mesothelioma patients. Survival rates diverge after several years, with lung cancer patients having a long-term survival advantage.
Beyond the statistics, though, is the need for someone with an asbestos cancer to secure an accurate diagnosis: Is it asbestos-related lung cancer or is it mesothelioma? The next step would be to formulate the best individual treatment plan.
Common Questions About Mesothelioma Vs. Lung Cancer
- Is mesothelioma a form of lung cancer?
While malignant mesothelioma is cancerous, it is not a form of lung cancer. Lung cancer develops inside the lungs, while mesothelioma causes tumors of the pleural tissue that surrounds the outside of the lungs, diaphragm and chest cavity. Both diseases share similar symptoms, such as shortness of breath and chest pain, and can be caused by inhaling asbestos fibers.
- What are the warning signs of mesothelioma?
The earliest signs of mesothelioma include:
- Shortness of breath
- Chest pain or discomfort
- Persistent cough
- Fever or night sweats
- Nausea, vomiting or diarrhea
- Abdominal pain or swelling
- Lack of appetite or weight loss
- Should you see a mesothelioma specialist if you have asbestos-related lung cancer?
Pleural mesothelioma doctors are a patient’s best resource for receiving accurate and effective treatment for asbestos-related lung cancer. These specialists have expertise in diagnosing and treating several asbestos-related diseases, and they understand the complexities of lung cancer caused by asbestos. Top mesothelioma doctors can also connect you with clinical research trials and specialized treatments for patients with asbestos-related lung cancer.
Thank you for your feedback. Would you like to speak with a Patient Advocate?